British Patient Capital comments on the British Business Bank’s Small Business Equity Tracker which reveals UK VCs currently have a record amount of dry powder ready to deploy.
British Patient Capital comments on the British Business Bank’s Small Business Equity Tracker which reveals UK VCs currently have a record amount of dry powder ready to deploy.Catherine Lewis La Torre says: “According to the British Business Bank’s Small Business Equity Tracker, venture capital dry powder – capital yet to be invested – is collectively worth GBP8.4 billion. equating to 12 to 15 months of investment based on 2018 and 2019 investment level. While clearly this isn’t all down to British Patient Capital, at 31 December 2019, British Patient Capital has already committed more than GBP1 billion to venture capital and venture growth managers, and just as importantly were joined by other institutional investors committing a further GBP4 billion alongside us. That’s GBP5 billion of capital, with GBP3 billion still to be invested in high-growth innovative companies.
“Ultimately this gives venture capital funds the firepower they need to continue to support UK innovative companies now and power the innovation economy as we emerge from the crisis.
“Further good news is that the Small Business Equity Tracker reveals that UK scale-ups are better capitalised now, with British Patient Capital supported funds almost doubling their deal count in 2019. Addressing the funding gap that has affected later-stage businesses, by enabling larger funding rounds, is central to our long-term vision for more home-grown fully funded, high growth companies to fulfil their potential to be players on the global stage.
“In addition to the record amounts of venture dry powder, I’m pleased to see that for the first time that follow on funding – investment in companies that had already received equity finance – outstripped first-time deals, which shows our innovative companies are able to raise multiple funding rounds. This, together with the significant amounts of institutional capital invested alongside British Patient Capital demonstrates the increasing importance of the private markets for institutional investors.
“Given negative bond-yields, asset owners are continuing to seek out higher returns from private markets. The Equity Tracker published today demonstrates a maturing of the market, as investors seek returns from unlisted companies in the UK technology sector, which accounted for 47% of investment by value in 2019.”
NEWSLETTER
Like this article?
SIGN UP NOW
UK VC reserves of GBP8.4bn could provide crucial funding as country emerges from crisis, says British Patient Capital
British Patient Capital comments on the British Business Bank’s Small Business Equity Tracker which reveals UK VCs currently have a record amount of dry powder ready to deploy.
British Patient Capital comments on the British Business Bank’s Small Business Equity Tracker which reveals UK VCs currently have a record amount of dry powder ready to deploy.Catherine Lewis La Torre says: “According to the British Business Bank’s Small Business Equity Tracker, venture capital dry powder – capital yet to be invested – is collectively worth GBP8.4 billion. equating to 12 to 15 months of investment based on 2018 and 2019 investment level. While clearly this isn’t all down to British Patient Capital, at 31 December 2019, British Patient Capital has already committed more than GBP1 billion to venture capital and venture growth managers, and just as importantly were joined by other institutional investors committing a further GBP4 billion alongside us. That’s GBP5 billion of capital, with GBP3 billion still to be invested in high-growth innovative companies.
“Ultimately this gives venture capital funds the firepower they need to continue to support UK innovative companies now and power the innovation economy as we emerge from the crisis.
“Further good news is that the Small Business Equity Tracker reveals that UK scale-ups are better capitalised now, with British Patient Capital supported funds almost doubling their deal count in 2019. Addressing the funding gap that has affected later-stage businesses, by enabling larger funding rounds, is central to our long-term vision for more home-grown fully funded, high growth companies to fulfil their potential to be players on the global stage.
“In addition to the record amounts of venture dry powder, I’m pleased to see that for the first time that follow on funding – investment in companies that had already received equity finance – outstripped first-time deals, which shows our innovative companies are able to raise multiple funding rounds. This, together with the significant amounts of institutional capital invested alongside British Patient Capital demonstrates the increasing importance of the private markets for institutional investors.
“Given negative bond-yields, asset owners are continuing to seek out higher returns from private markets. The Equity Tracker published today demonstrates a maturing of the market, as investors seek returns from unlisted companies in the UK technology sector, which accounted for 47% of investment by value in 2019.”
Like this article? Sign up to our free newsletter
MOST POPULAR
Baird Capital adds to PE teams in London and Chicago
Golub Capital holds $2bn final close of sixth credit opportunities fund
Bowmark adds to portfolio management and value creation team
Sculptor closes €354m European CLO XI
Blue Earth Capital partners with education impact fund manager Achieve Partners
FURTHER READING
Wealth management platform Sidekick appoints Alternatives Product Lead
Roark completes $9.6bn Subway deal
Infrastructure and private debt remain popular, says State Street
Goldman Sachs acquires environmental risk servicer Adler & Allan from Sun European
Genstar adds to strategic advisory board
Featured
Roark completes $9.6bn Subway deal
PE fund closings plummet in first quarter
Blackstone and Goldman to provide funding for $7bn L’Occitane buyout
CVC shares climb to €17 from €14 offer price
Blackstone to acquire Tropical Smoothie Cafe
Goldman looks to tap private credit markets for Beyond Meat cash